サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1121377

世界の単核球症診断市場：考察と予測 (2028年まで)

Global Mononucleosis Diagnostic Market Insights, Forecast to 2028
出版日: | 発行: QYResearch | ページ情報: 英文 110 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
世界の単核球症診断市場：考察と予測 (2028年まで)
出版日: 2022年09月02日
発行: QYResearch
ページ情報: 英文 110 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、単核球症診断 (Mononucleosis Diagnostic) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 レポート概要

  • 調査範囲
  • 市場分析：タイプ別
    • 世界の単核球症診断の市場規模成長率：タイプ別, 2017 VS 2021 VS 2028
    • Monospot Test
    • Complete Blood Count Test
    • Epstein Barr Virus (EBV) Antibody Test
  • 市場：アプリケーション別
    • 世界の単核球症診断の市場規模成長率：アプリケーション別, 2017 VS 2021 VS 2028
    • Hospitals
    • Laboratories
    • Others
  • 調査目的
  • 対象期間

第2章 世界の市場成長トレンド

  • 世界の単核球症診断の市場展望 (2017-2028)
  • 単核球症診断の市場成長トレンド：地域別
    • 単核球症診断 市場規模：地域別: 2017 VS 2021 VS 2028
    • 単核球症診断の市場規模実績：地域別 (2017-2022)
    • 単核球症診断の市場規模予測：地域別 (2023-2028)
  • 単核球症診断 市場動向
    • 単核球症診断 業界動向
    • 単核球症診断 市場の促進要因
    • 単核球症診断 市場の課題
    • 単核球症診断 市場の抑制要因

第3章 競合情勢：主要企業別

  • 世界の単核球症診断の上位企業：収益別
    • 世界の単核球症診断の上位企業：収益別 (2017-2022)
    • 世界の単核球症診断の収益シェア：企業別 (2017-2022)
  • 世界の単核球症診断の市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
  • 企業ランキング：単核球症診断の収益
  • 世界の単核球症診断 市場集中度
    • 世界の単核球症診断 市場集中度 (CR5 and HHI)
    • 世界の上位10・上位5企業： 単核球症診断の収益 2021
  • 単核球症診断の主要企業の本社および事業エリア
  • 主要企業 単核球症診断の製品ソリューションおよびサービス
  • 市場参入時期： 単核球症診断 市場
  • M&A, 拡張計画

第4章 単核球症診断 内訳データ：タイプ別

  • 世界の単核球症診断の市場規模実績：タイプ別 (2017-2022)
  • 世界の単核球症診断の市場規模予測：タイプ別 (2023-2028)

第5章 単核球症診断 内訳データ：アプリケーション別

  • 世界の単核球症診断の市場規模実績：アプリケーション別 (2017-2022)
  • 世界の単核球症診断の市場規模予測：アプリケーション別 (2023-2028)

第6章 北米

  • 北米の単核球症診断 市場規模 (2017-2028)
  • 北米の単核球症診断 市場規模：タイプ別
    • 北米の単核球症診断 市場規模：タイプ別 (2017-2022)
    • 北米の単核球症診断 市場規模：タイプ別 (2023-2028)
    • 北米の単核球症診断の市場シェア：タイプ別 (2017-2028)
  • 北米の単核球症診断 市場規模：アプリケーション別
    • 北米の単核球症診断 市場規模：アプリケーション別 (2017-2022)
    • 北米の単核球症診断 市場規模：アプリケーション別 (2023-2028)
    • 北米の単核球症診断の市場シェア：アプリケーション別 (2017-2028)
  • 北米の単核球症診断 市場規模：国別
    • 北米の単核球症診断 市場規模：国別 (2017-2022)
    • 北米の単核球症診断 市場規模：国別 (2023-2028)
    • 米国
    • カナダ

第7章 欧州

  • 欧州の単核球症診断 市場規模 (2017-2028)
  • 欧州の単核球症診断 市場規模：タイプ別
    • 欧州の単核球症診断 市場規模：タイプ別 (2017-2022)
    • 欧州の単核球症診断 市場規模：タイプ別 (2023-2028)
    • 欧州の単核球症診断の市場シェア：タイプ別 (2017-2028)
  • 欧州の単核球症診断 市場規模：アプリケーション別
    • 欧州の単核球症診断 市場規模：アプリケーション別 (2017-2022)
    • 欧州の単核球症診断 市場規模：アプリケーション別 (2023-2028)
    • 欧州の単核球症診断の市場シェア：アプリケーション別 (2017-2028)
  • 欧州の単核球症診断 市場規模：国別
    • 欧州の単核球症診断 市場規模：国別 (2017-2022)
    • 欧州の単核球症診断 市場規模：国別 (2023-2028)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア
    • 北欧

第8章 アジア太平洋地域

  • アジア太平洋地域 単核球症診断 市場規模 (2017-2028)
  • アジア太平洋地域 単核球症診断 市場規模：タイプ別
    • アジア太平洋地域 単核球症診断 市場規模：タイプ別 (2017-2022)
    • アジア太平洋地域 単核球症診断 市場規模：タイプ別 (2023-2028)
    • アジア太平洋地域 単核球症診断の市場シェア：タイプ別 (2017-2028)
  • アジア太平洋地域 単核球症診断 市場規模：アプリケーション別
    • アジア太平洋地域 単核球症診断 市場規模：アプリケーション別 (2017-2022)
    • アジア太平洋地域 単核球症診断 市場規模：アプリケーション別 (2023-2028)
    • アジア太平洋地域 単核球症診断の市場シェア：アプリケーション別 (2017-2028)
  • アジア太平洋地域 単核球症診断 市場規模：地域別
    • アジア太平洋地域 単核球症診断 市場規模：地域別 (2017-2022)
    • アジア太平洋地域 単核球症診断 市場規模：地域別 (2023-2028)
    • 中国
    • 日本
    • 韓国
    • 東南アジア
    • インド
    • オーストラリア

第9章 ラテンアメリカ

  • ラテンアメリカの単核球症診断 市場規模 (2017-2028)
  • ラテンアメリカの単核球症診断 市場規模：タイプ別
    • ラテンアメリカの単核球症診断 市場規模：タイプ別 (2017-2022)
    • ラテンアメリカの単核球症診断 市場規模：タイプ別 (2023-2028)
    • ラテンアメリカの単核球症診断の市場シェア：タイプ別 (2017-2028)
  • ラテンアメリカの単核球症診断 市場規模：アプリケーション別
    • ラテンアメリカの単核球症診断 市場規模：アプリケーション別 (2017-2022)
    • ラテンアメリカの単核球症診断 市場規模：アプリケーション別 (2023-2028)
    • ラテンアメリカの単核球症診断の市場シェア：アプリケーション別 (2017-2028)
  • ラテンアメリカの単核球症診断 市場規模：国別
    • ラテンアメリカの単核球症診断 市場規模：国別 (2017-2022)
    • ラテンアメリカの単核球症診断 市場規模：国別 (2023-2028)
    • メキシコ
    • ブラジル

第10章 中東・アフリカ

  • 中東・アフリカの単核球症診断 市場規模 (2017-2028)
  • 中東・アフリカの単核球症診断 市場規模：タイプ別
    • 中東・アフリカの単核球症診断 市場規模：タイプ別 (2017-2022)
    • 中東・アフリカの単核球症診断 市場規模：タイプ別 (2023-2028)
    • 中東・アフリカの単核球症診断の市場シェア：タイプ別 (2017-2028)
  • 中東・アフリカの単核球症診断 市場規模：アプリケーション別
    • 中東・アフリカの単核球症診断 市場規模：アプリケーション別 (2017-2022)
    • 中東・アフリカの単核球症診断 市場規模：アプリケーション別 (2023-2028)
    • 中東・アフリカの単核球症診断の市場シェア：アプリケーション別 (2017-2028)
  • 中東・アフリカの単核球症診断 市場規模：国別
    • 中東・アフリカの単核球症診断 市場規模：国別 (2017-2022)
    • 中東・アフリカの単核球症診断 市場規模：国別 (2023-2028)
    • トルコ
    • サウジアラビア
    • UAE

第11章 主要企業のプロファイル

  • Abbott Laboratories
  • ELITechGroup
  • Beckman Coulter
  • Bio-Rad Laboratories
  • Cardinal Health
  • Immunostics
  • Meridian Bioscience
  • Quidel Corporation
  • Sekisui Diagnostics
  • Thermo Fischer Scientific
  • Siemens
  • Biomerieux

第12章 アナリストによる分析/結論

第13章 付録

図表
  • Table 1. Global Mononucleosis Diagnostic Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
  • Table 2. Key Players of Monospot Test
  • Table 3. Key Players of Complete Blood Count Test
  • Table 4. Key Players of Epstein Barr Virus (EBV) Antibody Test
  • Table 5. Global Mononucleosis Diagnostic Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
  • Table 6. Global Mononucleosis Diagnostic Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
  • Table 7. Global Mononucleosis Diagnostic Market Size by Region (2017-2022) & (US$ Million)
  • Table 8. Global Mononucleosis Diagnostic Market Share by Region (2017-2022)
  • Table 9. Global Mononucleosis Diagnostic Forecasted Market Size by Region (2023-2028) & (US$ Million)
  • Table 10. Global Mononucleosis Diagnostic Market Share by Region (2023-2028)
  • Table 11. Mononucleosis Diagnostic Market Trends
  • Table 12. Mononucleosis Diagnostic Market Drivers
  • Table 13. Mononucleosis Diagnostic Market Challenges
  • Table 14. Mononucleosis Diagnostic Market Restraints
  • Table 15. Global Mononucleosis Diagnostic Revenue by Players (2017-2022) & (US$ Million)
  • Table 16. Global Mononucleosis Diagnostic Revenue Share by Players (2017-2022)
  • Table 17. Global Top Mononucleosis Diagnostic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mononucleosis Diagnostic as of 2021)
  • Table 18. Ranking of Global Top Mononucleosis Diagnostic Companies by Revenue (US$ Million) in 2021
  • Table 19. Global 5 Largest Players Market Share by Mononucleosis Diagnostic Revenue (CR5 and HHI) & (2017-2022)
  • Table 20. Key Players Headquarters and Area Served
  • Table 21. Key Players Mononucleosis Diagnostic Product Solution and Service
  • Table 22. Date of Enter into Mononucleosis Diagnostic Market
  • Table 23. Mergers & Acquisitions, Expansion Plans
  • Table 24. Global Mononucleosis Diagnostic Market Size by Type (2017-2022) & (US$ Million)
  • Table 25. Global Mononucleosis Diagnostic Revenue Market Share by Type (2017-2022)
  • Table 26. Global Mononucleosis Diagnostic Forecasted Market Size by Type (2023-2028) & (US$ Million)
  • Table 27. Global Mononucleosis Diagnostic Revenue Market Share by Type (2023-2028)
  • Table 28. Global Mononucleosis Diagnostic Market Size by Application (2017-2022) & (US$ Million)
  • Table 29. Global Mononucleosis Diagnostic Revenue Share by Application (2017-2022)
  • Table 30. Global Mononucleosis Diagnostic Forecasted Market Size by Application (2023-2028) & (US$ Million)
  • Table 31. Global Mononucleosis Diagnostic Revenue Share by Application (2023-2028)
  • Table 32. North America Mononucleosis Diagnostic Market Size by Type (2017-2022) & (US$ Million)
  • Table 33. North America Mononucleosis Diagnostic Market Size by Type (2023-2028) & (US$ Million)
  • Table 34. North America Mononucleosis Diagnostic Market Size by Application (2017-2022) & (US$ Million)
  • Table 35. North America Mononucleosis Diagnostic Market Size by Application (2023-2028) & (US$ Million)
  • Table 36. North America Mononucleosis Diagnostic Market Size by Country (2017-2022) & (US$ Million)
  • Table 37. North America Mononucleosis Diagnostic Market Size by Country (2023-2028) & (US$ Million)
  • Table 38. Europe Mononucleosis Diagnostic Market Size by Type (2017-2022) & (US$ Million)
  • Table 39. Europe Mononucleosis Diagnostic Market Size by Type (2023-2028) & (US$ Million)
  • Table 40. Europe Mononucleosis Diagnostic Market Size by Application (2017-2022) & (US$ Million)
  • Table 41. Europe Mononucleosis Diagnostic Market Size by Application (2023-2028) & (US$ Million)
  • Table 42. Europe Mononucleosis Diagnostic Market Size by Country (2017-2022) & (US$ Million)
  • Table 43. Europe Mononucleosis Diagnostic Market Size by Country (2023-2028) & (US$ Million)
  • Table 44. Asia Pacific Mononucleosis Diagnostic Market Size by Type (2017-2022) & (US$ Million)
  • Table 45. Asia Pacific Mononucleosis Diagnostic Market Size by Type (2023-2028) & (US$ Million)
  • Table 46. Asia Pacific Mononucleosis Diagnostic Market Size by Application (2017-2022) & (US$ Million)
  • Table 47. Asia Pacific Mononucleosis Diagnostic Market Size by Application (2023-2028) & (US$ Million)
  • Table 48. Asia Pacific Mononucleosis Diagnostic Market Size by Region (2017-2022) & (US$ Million)
  • Table 49. Asia Pacific Mononucleosis Diagnostic Market Size by Region (2023-2028) & (US$ Million)
  • Table 50. Latin America Mononucleosis Diagnostic Market Size by Type (2017-2022) & (US$ Million)
  • Table 51. Latin America Mononucleosis Diagnostic Market Size by Type (2023-2028) & (US$ Million)
  • Table 52. Latin America Mononucleosis Diagnostic Market Size by Application (2017-2022) & (US$ Million)
  • Table 53. Latin America Mononucleosis Diagnostic Market Size by Application (2023-2028) & (US$ Million)
  • Table 54. Latin America Mononucleosis Diagnostic Market Size by Country (2017-2022) & (US$ Million)
  • Table 55. Latin America Mononucleosis Diagnostic Market Size by Country (2023-2028) & (US$ Million)
  • Table 56. Middle East and Africa Mononucleosis Diagnostic Market Size by Type (2017-2022) & (US$ Million)
  • Table 57. Middle East and Africa Mononucleosis Diagnostic Market Size by Type (2023-2028) & (US$ Million)
  • Table 58. Middle East and Africa Mononucleosis Diagnostic Market Size by Application (2017-2022) & (US$ Million)
  • Table 59. Middle East and Africa Mononucleosis Diagnostic Market Size by Application (2023-2028) & (US$ Million)
  • Table 60. Middle East and Africa Mononucleosis Diagnostic Market Size by Country (2017-2022) & (US$ Million)
  • Table 61. Middle East and Africa Mononucleosis Diagnostic Market Size by Country (2023-2028) & (US$ Million)
  • Table 62. Abbott Laboratories Company Details
  • Table 63. Abbott Laboratories Business Overview
  • Table 64. Abbott Laboratories Mononucleosis Diagnostic Product
  • Table 65. Abbott Laboratories Revenue in Mononucleosis Diagnostic Business (2017-2022) & (US$ Million)
  • Table 66. Abbott Laboratories Recent Developments
  • Table 67. ELITechGroup Company Details
  • Table 68. ELITechGroup Business Overview
  • Table 69. ELITechGroup Mononucleosis Diagnostic Product
  • Table 70. ELITechGroup Revenue in Mononucleosis Diagnostic Business (2017-2022) & (US$ Million)
  • Table 71. ELITechGroup Recent Developments
  • Table 72. Beckman Coulter Company Details
  • Table 73. Beckman Coulter Business Overview
  • Table 74. Beckman Coulter Mononucleosis Diagnostic Product
  • Table 75. Beckman Coulter Revenue in Mononucleosis Diagnostic Business (2017-2022) & (US$ Million)
  • Table 76. Beckman Coulter Recent Developments
  • Table 77. Bio-Rad Laboratories Company Details
  • Table 78. Bio-Rad Laboratories Business Overview
  • Table 79. Bio-Rad Laboratories Mononucleosis Diagnostic Product
  • Table 80. Bio-Rad Laboratories Revenue in Mononucleosis Diagnostic Business (2017-2022) & (US$ Million)
  • Table 81. Bio-Rad Laboratories Recent Developments
  • Table 82. Cardinal Health Company Details
  • Table 83. Cardinal Health Business Overview
  • Table 84. Cardinal Health Mononucleosis Diagnostic Product
  • Table 85. Cardinal Health Revenue in Mononucleosis Diagnostic Business (2017-2022) & (US$ Million)
  • Table 86. Cardinal Health Recent Developments
  • Table 87. Immunostics Company Details
  • Table 88. Immunostics Business Overview
  • Table 89. Immunostics Mononucleosis Diagnostic Product
  • Table 90. Immunostics Revenue in Mononucleosis Diagnostic Business (2017-2022) & (US$ Million)
  • Table 91. Immunostics Recent Developments
  • Table 92. Meridian Bioscience Company Details
  • Table 93. Meridian Bioscience Business Overview
  • Table 94. Meridian Bioscience Mononucleosis Diagnostic Product
  • Table 95. Meridian Bioscience Revenue in Mononucleosis Diagnostic Business (2017-2022) & (US$ Million)
  • Table 96. Meridian Bioscience Recent Developments
  • Table 97. Quidel Corporation Company Details
  • Table 98. Quidel Corporation Business Overview
  • Table 99. Quidel Corporation Mononucleosis Diagnostic Product
  • Table 100. Quidel Corporation Revenue in Mononucleosis Diagnostic Business (2017-2022) & (US$ Million)
  • Table 101. Quidel Corporation Recent Developments
  • Table 102. Sekisui Diagnostics Company Details
  • Table 103. Sekisui Diagnostics Business Overview
  • Table 104. Sekisui Diagnostics Mononucleosis Diagnostic Product
  • Table 105. Sekisui Diagnostics Revenue in Mononucleosis Diagnostic Business (2017-2022) & (US$ Million)
  • Table 106. Sekisui Diagnostics Recent Developments
  • Table 107. Thermo Fischer Scientific Company Details
  • Table 108. Thermo Fischer Scientific Business Overview
  • Table 109. Thermo Fischer Scientific Mononucleosis Diagnostic Product
  • Table 110. Thermo Fischer Scientific Revenue in Mononucleosis Diagnostic Business (2017-2022) & (US$ Million)
  • Table 111. Thermo Fischer Scientific Recent Developments
  • Table 112. Siemens Company Details
  • Table 113. Siemens Business Overview
  • Table 114. Siemens Mononucleosis Diagnostic Product
  • Table 115. Siemens Revenue in Mononucleosis Diagnostic Business (2017-2022) & (US$ Million)
  • Table 116. Siemens Recent Developments
  • Table 117. Biomerieux Company Details
  • Table 118. Biomerieux Business Overview
  • Table 119. Biomerieux Mononucleosis Diagnostic Product
  • Table 120. Biomerieux Revenue in Mononucleosis Diagnostic Business (2017-2022) & (US$ Million)
  • Table 121. Biomerieux Recent Developments
  • Table 122. Research Programs/Design for This Report
  • Table 123. Key Data Information from Secondary Sources
  • Table 124. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Mononucleosis Diagnostic Market Share by Type: 2021 VS 2028
  • Figure 2. Monospot Test Features
  • Figure 3. Complete Blood Count Test Features
  • Figure 4. Epstein Barr Virus (EBV) Antibody Test Features
  • Figure 5. Global Mononucleosis Diagnostic Market Share by Application: 2021 VS 2028
  • Figure 6. Hospitals Case Studies
  • Figure 7. Laboratories Case Studies
  • Figure 8. Others Case Studies
  • Figure 9. Mononucleosis Diagnostic Report Years Considered
  • Figure 10. Global Mononucleosis Diagnostic Market Size (US$ Million), Year-over-Year: 2017-2028
  • Figure 11. Global Mononucleosis Diagnostic Market Size, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 12. Global Mononucleosis Diagnostic Market Share by Region: 2021 VS 2028
  • Figure 13. Global Mononucleosis Diagnostic Market Share by Players in 2021
  • Figure 14. Global Top Mononucleosis Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mononucleosis Diagnostic as of 2021)
  • Figure 15. The Top 10 and 5 Players Market Share by Mononucleosis Diagnostic Revenue in 2021
  • Figure 16. North America Mononucleosis Diagnostic Market Size YoY (2017-2028) & (US$ Million)
  • Figure 17. North America Mononucleosis Diagnostic Market Size Market Share by Type (2017-2028)
  • Figure 18. North America Mononucleosis Diagnostic Market Size Market Share by Application (2017-2028)
  • Figure 19. North America Mononucleosis Diagnostic Market Size Share by Country (2017-2028)
  • Figure 20. United States Mononucleosis Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 21. Canada Mononucleosis Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 22. Europe Mononucleosis Diagnostic Market Size YoY (2017-2028) & (US$ Million)
  • Figure 23. Europe Mononucleosis Diagnostic Market Size Market Share by Type (2017-2028)
  • Figure 24. Europe Mononucleosis Diagnostic Market Size Market Share by Application (2017-2028)
  • Figure 25. Europe Mononucleosis Diagnostic Market Size Share by Country (2017-2028)
  • Figure 26. Germany Mononucleosis Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 27. France Mononucleosis Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 28. U.K. Mononucleosis Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 29. Italy Mononucleosis Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 30. Russia Mononucleosis Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 31. Nordic Countries Mononucleosis Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 32. Asia-Pacific Mononucleosis Diagnostic Market Size YoY (2017-2028) & (US$ Million)
  • Figure 33. Asia Pacific Mononucleosis Diagnostic Market Size Market Share by Type (2017-2028)
  • Figure 34. Asia Pacific Mononucleosis Diagnostic Market Size Market Share by Application (2017-2028)
  • Figure 35. Asia Pacific Mononucleosis Diagnostic Market Size Share by Region (2017-2028)
  • Figure 36. China Mononucleosis Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 37. Japan Mononucleosis Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 38. South Korea Mononucleosis Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 39. Southeast Asia Mononucleosis Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 40. India Mononucleosis Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 41. Australia Mononucleosis Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

  • Figure 42. Latin America Mononucleosis Diagnostic Market Size YoY (2017-2028) & (US$ Million)
  • Figure 43. Latin America Mononucleosis Diagnostic Market Size Market Share by Type (2017-2028)
  • Figure 44. Latin America Mononucleosis Diagnostic Market Size Market Share by Application (2017-2028)
  • Figure 45. Latin America Mononucleosis Diagnostic Market Size Share by Country (2017-2028)
  • Figure 46. Mexico Mononucleosis Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 47. Brazil Mononucleosis Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 48. Middle East & Africa Mononucleosis Diagnostic Market Size YoY (2017-2028) & (US$ Million)
  • Figure 49. Middle East and Africa Mononucleosis Diagnostic Market Size Market Share by Type (2017-2028)
  • Figure 50. Middle East and Africa Mononucleosis Diagnostic Market Size Market Share by Application (2017-2028)
  • Figure 51. Middle East and Africa Mononucleosis Diagnostic Market Size Share by Country (2017-2028)
  • Figure 52. Turkey Mononucleosis Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 53. Saudi Arabia Mononucleosis Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 54. UAE Mononucleosis Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 55. Abbott Laboratories Revenue Growth Rate in Mononucleosis Diagnostic Business (2017-2022)
  • Figure 56. ELITechGroup Revenue Growth Rate in Mononucleosis Diagnostic Business (2017-2022)
  • Figure 57. Beckman Coulter Revenue Growth Rate in Mononucleosis Diagnostic Business (2017-2022)
  • Figure 58. Bio-Rad Laboratories Revenue Growth Rate in Mononucleosis Diagnostic Business (2017-2022)
  • Figure 59. Cardinal Health Revenue Growth Rate in Mononucleosis Diagnostic Business (2017-2022)
  • Figure 60. Immunostics Revenue Growth Rate in Mononucleosis Diagnostic Business (2017-2022)
  • Figure 61. Meridian Bioscience Revenue Growth Rate in Mononucleosis Diagnostic Business (2017-2022)
  • Figure 62. Quidel Corporation Revenue Growth Rate in Mononucleosis Diagnostic Business (2017-2022)
  • Figure 63. Sekisui Diagnostics Revenue Growth Rate in Mononucleosis Diagnostic Business (2017-2022)
  • Figure 64. Thermo Fischer Scientific Revenue Growth Rate in Mononucleosis Diagnostic Business (2017-2022)
  • Figure 65. Siemens Revenue Growth Rate in Mononucleosis Diagnostic Business (2017-2022)
  • Figure 66. Biomerieux Revenue Growth Rate in Mononucleosis Diagnostic Business (2017-2022)
  • Figure 67. Bottom-up and Top-down Approaches for This Report
  • Figure 68. Data Triangulation
  • Figure 69. Key Executives Interviewed
目次

This research report focuses on the Mononucleosis Diagnostic Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Business Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Mononucleosis Diagnostic Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Monospot Test
    • 1.2.3 Complete Blood Count Test
    • 1.2.4 Epstein Barr Virus (EBV) Antibody Test
  • 1.3 Market by Application
    • 1.3.1 Global Mononucleosis Diagnostic Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Hospitals
    • 1.3.3 Laboratories
    • 1.3.4 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Mononucleosis Diagnostic Market Perspective (2017-2028)
  • 2.2 Mononucleosis Diagnostic Growth Trends by Region
    • 2.2.1 Mononucleosis Diagnostic Market Size by Region: 2017 VS 2021 VS 2028
    • 2.2.2 Mononucleosis Diagnostic Historic Market Size by Region (2017-2022)
    • 2.2.3 Mononucleosis Diagnostic Forecasted Market Size by Region (2023-2028)
  • 2.3 Mononucleosis Diagnostic Market Dynamics
    • 2.3.1 Mononucleosis Diagnostic Industry Trends
    • 2.3.2 Mononucleosis Diagnostic Market Drivers
    • 2.3.3 Mononucleosis Diagnostic Market Challenges
    • 2.3.4 Mononucleosis Diagnostic Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Mononucleosis Diagnostic Players by Revenue
    • 3.1.1 Global Top Mononucleosis Diagnostic Players by Revenue (2017-2022)
    • 3.1.2 Global Mononucleosis Diagnostic Revenue Market Share by Players (2017-2022)
  • 3.2 Global Mononucleosis Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Players Covered: Ranking by Mononucleosis Diagnostic Revenue
  • 3.4 Global Mononucleosis Diagnostic Market Concentration Ratio
    • 3.4.1 Global Mononucleosis Diagnostic Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Mononucleosis Diagnostic Revenue in 2021
  • 3.5 Mononucleosis Diagnostic Key Players Head office and Area Served
  • 3.6 Key Players Mononucleosis Diagnostic Product Solution and Service
  • 3.7 Date of Enter into Mononucleosis Diagnostic Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Mononucleosis Diagnostic Breakdown Data by Type

  • 4.1 Global Mononucleosis Diagnostic Historic Market Size by Type (2017-2022)
  • 4.2 Global Mononucleosis Diagnostic Forecasted Market Size by Type (2023-2028)

5 Mononucleosis Diagnostic Breakdown Data by Application

  • 5.1 Global Mononucleosis Diagnostic Historic Market Size by Application (2017-2022)
  • 5.2 Global Mononucleosis Diagnostic Forecasted Market Size by Application (2023-2028)

6 North America

  • 6.1 North America Mononucleosis Diagnostic Market Size (2017-2028)
  • 6.2 North America Mononucleosis Diagnostic Market Size by Type
    • 6.2.1 North America Mononucleosis Diagnostic Market Size by Type (2017-2022)
    • 6.2.2 North America Mononucleosis Diagnostic Market Size by Type (2023-2028)
    • 6.2.3 North America Mononucleosis Diagnostic Market Share by Type (2017-2028)
  • 6.3 North America Mononucleosis Diagnostic Market Size by Application
    • 6.3.1 North America Mononucleosis Diagnostic Market Size by Application (2017-2022)
    • 6.3.2 North America Mononucleosis Diagnostic Market Size by Application (2023-2028)
    • 6.3.3 North America Mononucleosis Diagnostic Market Share by Application (2017-2028)
  • 6.4 North America Mononucleosis Diagnostic Market Size by Country
    • 6.4.1 North America Mononucleosis Diagnostic Market Size by Country (2017-2022)
    • 6.4.2 North America Mononucleosis Diagnostic Market Size by Country (2023-2028)
    • 6.4.3 U.S.
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Mononucleosis Diagnostic Market Size (2017-2028)
  • 7.2 Europe Mononucleosis Diagnostic Market Size by Type
    • 7.2.1 Europe Mononucleosis Diagnostic Market Size by Type (2017-2022)
    • 7.2.2 Europe Mononucleosis Diagnostic Market Size by Type (2023-2028)
    • 7.2.3 Europe Mononucleosis Diagnostic Market Share by Type (2017-2028)
  • 7.3 Europe Mononucleosis Diagnostic Market Size by Application
    • 7.3.1 Europe Mononucleosis Diagnostic Market Size by Application (2017-2022)
    • 7.3.2 Europe Mononucleosis Diagnostic Market Size by Application (2023-2028)
    • 7.3.3 Europe Mononucleosis Diagnostic Market Share by Application (2017-2028)
  • 7.4 Europe Mononucleosis Diagnostic Market Size by Country
    • 7.4.1 Europe Mononucleosis Diagnostic Market Size by Country (2017-2022)
    • 7.4.2 Europe Mononucleosis Diagnostic Market Size by Country (2023-2028)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 Asia-Pacific

  • 8.1 Asia-Pacific Mononucleosis Diagnostic Market Size (2017-2028)
  • 8.2 Asia-Pacific Mononucleosis Diagnostic Market Size by Type
    • 8.2.1 Asia-Pacific Mononucleosis Diagnostic Market Size by Type (2017-2022)
    • 8.2.2 Asia-Pacific Mononucleosis Diagnostic Market Size by Type (2023-2028)
    • 8.2.3 Asia-Pacific Mononucleosis Diagnostic Market Share by Type (2017-2028)
  • 8.3 Asia-Pacific Mononucleosis Diagnostic Market Size by Application
    • 8.3.1 Asia-Pacific Mononucleosis Diagnostic Market Size by Application (2017-2022)
    • 8.3.2 Asia-Pacific Mononucleosis Diagnostic Market Size by Application (2023-2028)
    • 8.3.3 Asia-Pacific Mononucleosis Diagnostic Market Share by Application (2017-2028)
  • 8.4 Asia-Pacific Mononucleosis Diagnostic Market Size by Region
    • 8.4.1 Asia-Pacific Mononucleosis Diagnostic Market Size by Region (2017-2022)
    • 8.4.2 Asia-Pacific Mononucleosis Diagnostic Market Size by Region (2023-2028)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Mononucleosis Diagnostic Market Size (2017-2028)
  • 9.2 Latin America Mononucleosis Diagnostic Market Size by Type
    • 9.2.1 Latin America Mononucleosis Diagnostic Market Size by Type (2017-2022)
    • 9.2.2 Latin America Mononucleosis Diagnostic Market Size by Type (2023-2028)
    • 9.2.3 Latin America Mononucleosis Diagnostic Market Share by Type (2017-2028)
  • 9.3 Latin America Mononucleosis Diagnostic Market Size by Application
    • 9.3.1 Latin America Mononucleosis Diagnostic Market Size by Application (2017-2022)
    • 9.3.2 Latin America Mononucleosis Diagnostic Market Size by Application (2023-2028)
    • 9.3.3 Latin America Mononucleosis Diagnostic Market Share by Application (2017-2028)
  • 9.4 Latin America Mononucleosis Diagnostic Market Size by Country
    • 9.4.1 Latin America Mononucleosis Diagnostic Market Size by Country (2017-2022)
    • 9.4.2 Latin America Mononucleosis Diagnostic Market Size by Country (2023-2028)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Mononucleosis Diagnostic Market Size (2017-2028)
  • 10.2 Middle East & Africa Mononucleosis Diagnostic Market Size by Type
    • 10.2.1 Middle East & Africa Mononucleosis Diagnostic Market Size by Type (2017-2022)
    • 10.2.2 Middle East & Africa Mononucleosis Diagnostic Market Size by Type (2023-2028)
    • 10.2.3 Middle East & Africa Mononucleosis Diagnostic Market Share by Type (2017-2028)
  • 10.3 Middle East & Africa Mononucleosis Diagnostic Market Size by Application
    • 10.3.1 Middle East & Africa Mononucleosis Diagnostic Market Size by Application (2017-2022)
    • 10.3.2 Middle East & Africa Mononucleosis Diagnostic Market Size by Application (2023-2028)
    • 10.3.3 Middle East & Africa Mononucleosis Diagnostic Market Share by Application (2017-2028)
  • 10.4 Middle East & Africa Mononucleosis Diagnostic Market Size by Country
    • 10.4.1 Middle East & Africa Mononucleosis Diagnostic Market Size by Country (2017-2022)
    • 10.4.2 Middle East & Africa Mononucleosis Diagnostic Market Size by Country (2023-2028)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Abbott Laboratories
    • 11.1.1 Abbott Laboratories Company Details
    • 11.1.2 Abbott Laboratories Business Overview
    • 11.1.3 Abbott Laboratories Mononucleosis Diagnostic Introduction
    • 11.1.4 Abbott Laboratories Revenue in Mononucleosis Diagnostic Business (2017-2022)
    • 11.1.5 Abbott Laboratories Recent Developments
  • 11.2 ELITechGroup
    • 11.2.1 ELITechGroup Company Details
    • 11.2.2 ELITechGroup Business Overview
    • 11.2.3 ELITechGroup Mononucleosis Diagnostic Introduction
    • 11.2.4 ELITechGroup Revenue in Mononucleosis Diagnostic Business (2017-2022)
    • 11.2.5 ELITechGroup Recent Developments
  • 11.3 Beckman Coulter
    • 11.3.1 Beckman Coulter Company Details
    • 11.3.2 Beckman Coulter Business Overview
    • 11.3.3 Beckman Coulter Mononucleosis Diagnostic Introduction
    • 11.3.4 Beckman Coulter Revenue in Mononucleosis Diagnostic Business (2017-2022)
    • 11.3.5 Beckman Coulter Recent Developments
  • 11.4 Bio-Rad Laboratories
    • 11.4.1 Bio-Rad Laboratories Company Details
    • 11.4.2 Bio-Rad Laboratories Business Overview
    • 11.4.3 Bio-Rad Laboratories Mononucleosis Diagnostic Introduction
    • 11.4.4 Bio-Rad Laboratories Revenue in Mononucleosis Diagnostic Business (2017-2022)
    • 11.4.5 Bio-Rad Laboratories Recent Developments
  • 11.5 Cardinal Health
    • 11.5.1 Cardinal Health Company Details
    • 11.5.2 Cardinal Health Business Overview
    • 11.5.3 Cardinal Health Mononucleosis Diagnostic Introduction
    • 11.5.4 Cardinal Health Revenue in Mononucleosis Diagnostic Business (2017-2022)
    • 11.5.5 Cardinal Health Recent Developments
  • 11.6 Immunostics
    • 11.6.1 Immunostics Company Details
    • 11.6.2 Immunostics Business Overview
    • 11.6.3 Immunostics Mononucleosis Diagnostic Introduction
    • 11.6.4 Immunostics Revenue in Mononucleosis Diagnostic Business (2017-2022)
    • 11.6.5 Immunostics Recent Developments
  • 11.7 Meridian Bioscience
    • 11.7.1 Meridian Bioscience Company Details
    • 11.7.2 Meridian Bioscience Business Overview
    • 11.7.3 Meridian Bioscience Mononucleosis Diagnostic Introduction
    • 11.7.4 Meridian Bioscience Revenue in Mononucleosis Diagnostic Business (2017-2022)
    • 11.7.5 Meridian Bioscience Recent Developments
  • 11.8 Quidel Corporation
    • 11.8.1 Quidel Corporation Company Details
    • 11.8.2 Quidel Corporation Business Overview
    • 11.8.3 Quidel Corporation Mononucleosis Diagnostic Introduction
    • 11.8.4 Quidel Corporation Revenue in Mononucleosis Diagnostic Business (2017-2022)
    • 11.8.5 Quidel Corporation Recent Developments
  • 11.9 Sekisui Diagnostics
    • 11.9.1 Sekisui Diagnostics Company Details
    • 11.9.2 Sekisui Diagnostics Business Overview
    • 11.9.3 Sekisui Diagnostics Mononucleosis Diagnostic Introduction
    • 11.9.4 Sekisui Diagnostics Revenue in Mononucleosis Diagnostic Business (2017-2022)
    • 11.9.5 Sekisui Diagnostics Recent Developments
  • 11.10 Thermo Fischer Scientific
    • 11.10.1 Thermo Fischer Scientific Company Details
    • 11.10.2 Thermo Fischer Scientific Business Overview
    • 11.10.3 Thermo Fischer Scientific Mononucleosis Diagnostic Introduction
    • 11.10.4 Thermo Fischer Scientific Revenue in Mononucleosis Diagnostic Business (2017-2022)
    • 11.10.5 Thermo Fischer Scientific Recent Developments
  • 11.11 Siemens
    • 11.11.1 Siemens Company Details
    • 11.11.2 Siemens Business Overview
    • 11.11.3 Siemens Mononucleosis Diagnostic Introduction
    • 11.11.4 Siemens Revenue in Mononucleosis Diagnostic Business (2017-2022)
    • 11.11.5 Siemens Recent Developments
  • 11.12 Biomerieux
    • 11.12.1 Biomerieux Company Details
    • 11.12.2 Biomerieux Business Overview
    • 11.12.3 Biomerieux Mononucleosis Diagnostic Introduction
    • 11.12.4 Biomerieux Revenue in Mononucleosis Diagnostic Business (2017-2022)
    • 11.12.5 Biomerieux Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Author Details
  • 13.3 Disclaimer